Ligand profile
ZINC2510814
Virtual-screening candidate from ZINC.
Bound to: KP13_01374 — NADH pyrophosphatase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC2510814- UniProt (similar protein)
Q9CA40- Tanimoto
- 0.667
- Target protein
- KP13_01374
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 159.2
- −1 ≤ LogP ≤ 5 -2.36
- MW ≤ 500 Da 283.2
- LogP ≤ 5 -2.36
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 159.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Nc1nc2c([nH]c(=O)n2[C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]1Nc1nc2c([nH]c(=O)n2[C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]1
InChI=1S/C10H13N5O5/c11-9-13-7-6(8(18)14-9)12-10(19)15(7)5-1-3(17)4(2-16)20-5/h3-5,16-17H,1-2H2,(H,12,19)(H3,11,13,14,18)/t3-,4+,5+/m1/s1InChI=1S/C10H13N5O5/c11-9-13-7-6(8(18)14-9)12-10(19)15(7)5-1-3(17)4(2-16)20-5/h3-5,16-17H,1-2H2,(H,12,19)(H3,11,13,14,18)/t3-,4+,5+/m1/s1
HCAJQHYUCKICQH-WISUUJSJSA-NHCAJQHYUCKICQH-WISUUJSJSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 8DG
- Homolog
- Q9CA40
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC2510814 →
- ZINC ZINC20 ZINC2510814 →
- UniProt UniProt Q9CA40 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC2510814”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01374.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).